High KRT8 expression promotes tumor progression and metastasis of gastric cancer. Issue 2 (February 2017)

• Record Type: Journal Article
• Authors: Fang, Jian; Wang, Hao; Liu, Yun; Ding, Fangfang; Ni, Ying; Shao, Shihe
• Is Part Of: Cancer science. Volume 108:Issue 2(2017)
• Page Start: 178
• Page End: 186
• Publication Date: 2017-02
• Subjects: Gastric cancer -- Keratin -- Keratin8 -- metastasis -- survival; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13120
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : Keratin8 (KRT8) is the major component of the intermediate filament cytoskeleton and predominantly expressed in simple epithelial tissues. Aberrant expression of KRT8 is associated with multiple tumor progression and metastasis. However, the role of KRT8 in gastric cancer (GC) remains unclear. In this study, KRT8 expression was investigated and it was found to be upregulated along with human GC progression and metastasis at both mRNA and protein levels in human gastric cancer tissues. In addition, KRT8 overexpression enhanced the proliferation and migration of human gastric cancer cells, whereas the knock‐down of KRT8 by siRNA only inhibited migration of human gastric cancer cells. Integrinβ1‐FAK‐induced epithelial‐mesenchymal‐transition (EMT) only existed in the high KRT8 cells. Furthermore, KRT8 overexpression led to increase in p‐smad2/3 levels and TGFβ dependent signaling events. KRT8 expression in GC was related to tumor clinical stage and worse survival. Kaplan–Meier analysis proved that KRT8 was associated with overall survival of patients with GC that patients with high KRT8 expression tend to have unfavorable outcome. Moreover, Cox's proportional hazards analysis showed that high KRT8 expression was a prognostic marker of poor outcome. These results provided that KRT8 expression may therefore be a biomarker or potential therapeutic target to identify patients with worse survival. Abstract : High expression of KRT8 contributes to GC progression such as tumor invasion depth, clinical stage and poor survival. The findings also demonstrate the potential role of KRT8 as a diagnostic and prognostic indicator for GC patients.